Evidence map›Paper›PMID 25829232›Full record

ArticleClinical immunology (Orlando, Fla.)2015

T cell PKCδ kinase inactivation induces lupus-like autoimmunity in mice.

Gabriela Gorelik, Amr H Sawalha, Dipak Patel, Kent Johnson, Bruce Richardson

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The metabolomics of a protein kinase C delta (PKCδ) knock-out mouse model.Metabolomics : Official journal of the Metabolomic Society · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Epigenetics in SLE.Current rheumatology reports · 2017
    Review
  16. Review
  17. Article
  18. Protein Kinase C δ: a Gatekeeper of Immune Homeostasis.Journal of clinical immunology · 2016
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gabriela GorelikDepartment of Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: ggorelik@umich.edu.
Amr H SawalhaDepartment of Medicine, University of Michigan, Ann Arbor, MI, USA.
Dipak PatelDepartment of Medicine, University of Michigan, Ann Arbor, MI, USA.
Kent JohnsonDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.
Bruce RichardsonDepartment of Medicine, University of Michigan, Ann Arbor, MI, USA; Ann Arbor VA Medical Center, Ann Arbor, MI, USA.
University of Michigan · US

Funding

Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Research Training in BiogerontologyT32AG000114 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCOTT PLETCHER · 1985 to 2026
$12.4M
Research DevelopmentP30AG013283 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MILLER, RICHARD A · 1995 to 2014
$12.3M
T-CELLS AND THE INDUCTION OF LUPUSR01AR042525 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RICHARDSON, BRUCE C. · 1993 to 2013
$3.8M
UNIVERSITY OF MICHIGAN MULTIPURPOSE ARTHRITIS CENTERP60AR020557 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SOWERS, MARYFRAN R · 1986 to 2001
$2.9M
Aberrant gene expression in CD4+CD28-T cells: mechanismsR01AG025877 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RICHARDSON, BRUCE C. · 2006 to 2010
$1.5M
Environmental effects on lupus T cell DNA methylation and gene expressionR01ES015214 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RICHARDSON, BRUCE C. · 2006 to 2009
$1.5M
NIAMS NIH HHS AR20557NIAMS NIH HHS AR4525NIAMS NIH HHS R01 AR042525NIA NIH HHS AG25877NIA NIH HHS P30 AG013283NIA NIH HHS P30AG013283NIA NIH HHS R01 AG025877NIA NIH HHS T32 AG000114NIEHS NIH HHS ES015214NIEHS NIH HHS P30 ES017885NIEHS NIH HHS R01 ES015214
6 · The paper itself

Abstract

Genetic and environmental factors contribute to the onset and progression of lupus. CD4+ T cells from patients with active lupus show a decreased ERK signaling pathway, which causes changes in gene expression. The defect points to its upstream regulator, PKCδ, which exhibits a deficient activity due to oxidative stress. Our aim was to investigate the effect of a defective PKCδ in the development of lupus. We generated a double transgenic C57BL6 × SJL mouse that expresses a doxycycline-induced dominant negative PKCδ (dnPKCδ) in T cells. The transgenic mice displayed decreased T cell ERK signaling, decreased DNMT1 expression and overexpression of methylation sensitive genes involved in the exaggerated immune response in the pathogenesis of lupus. The mice developed anti-dsDNA autoantibodies and glomerulonephritis with IgG deposition. The study indicates common pathogenic mechanisms with human lupus, suggesting that environmentally-mediated T cell PKCδ inactivation plays a causative role in lupus.

Indexed as

AnimalsAnti-Bacterial AgentsAutoantibodiesAutoimmunityDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDoxycyclineExtracellular Signal-Regulated MAP KinasesGene Expression Regulation, EnzymologicGlomerulonephritisImmunoglobulin GLupus Erythematosus, SystemicMiceMice, TransgenicMutationPhosphorylationAnti-Bacterial AgentsAutoantibodiesDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDNMT1 protein, humanDnmt1 protein, mouseDoxycyclineExtracellular Signal-Regulated MAP KinasesImmunoglobulin GProtein Kinase C-deltaTrans-ActivatorsAutoimmunityExtracellular signal-regulated kinase (ERK)LupusPKCδT cellsTransgenic mouse model

Identifiers

PMID25829232
PMCPMC4464903
OpenAlexW2088917338

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.